Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-05-019327
Filing Date
2005-04-29
Accepted
2005-04-29 16:27:44
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a05-6956_110ka.htm 10-K/A 165181
2 EX-23.2 a05-6956_1ex23d2.htm EX-23.2 3323
3 EX-31.1 a05-6956_1ex31d1.htm EX-31.1 9201
4 EX-31.2 a05-6956_1ex31d2.htm EX-31.2 9254
5 EX-32.1 a05-6956_1ex32d1.htm EX-32.1 5290
6 EX-32.2 a05-6956_1ex32d2.htm EX-32.2 5147
  Complete submission text file 0001104659-05-019327.txt   198862
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: 10-K/A | Act: 34 | File No.: 001-12493 | Film No.: 05786392
SIC: 2836 Biological Products, (No Diagnostic Substances)